Panel Discussion | CMD - What Is Next?

Sunday, March 8, 2026

11:12 AM - 11:45 AM EST

Location: Lincoln

Moderator(s)

Shrilla Banerjee, MD, FRCP, FESC

Consultant Interventional Cardiologist
Surrey and Sussex Healthcare NHS Trust
Redhill, England, United Kingdom

Disclosure(s): General Electric: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 10, 2025)
Nathaniel R. Smilowitz, MD

Assistant Professor of Medicine
NYU Langone Health
New York, New York, United States

Disclosure(s): Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing); AngioInsight: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)
Pieter C. Smits, PhD, FESC

Chief Medical Director
CERC (Cardiovascular European Research Center)
Rotterdam, Zuid-Holland, Netherlands

Disclosure information not submitted.

Panel Discussant(s)

Brian C. Case, MD

Interventional Cardiologist; Assistant Professor of Medicine, Georgetown University; Director of Cath Lab, Chief of Interventional Cardiology, MedStar Southern Maryland Hospital
MedStar Heart and Vascular Institute
Bethesda, Maryland, United States

Disclosure(s): Acist Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Jeff W. Chambers, MD, FSCAI, FACC

Director of the percutaneous Coronary Interventions
Metropolitian Heart and Vascular Institute
Minneapolis, Minnesota, United States

Disclosure(s): Zoll/Therox: Consulting Fees (e.g., advisory boards) (Ongoing)
Timothy D. Henry, MD

Director, The Carl and Edyth Lindner Center for Research and Education
The Christ Hospital
Bellevue, Kentucky, United States

Disclosure(s): No financial relationships to disclose
Jean-Michel Paradis, MD

Structural and Interventional Cardiologist
Quebec Heart and Lung Institute
Quebec, Quebec, Canada

Disclosure(s): No financial relationships to disclose
Janet Wei, MD

Associate Professor, Cardiology and Biomedical Sciences
Cedars-Sinai Smidt Heart Institute

Disclosure(s): No financial relationships to disclose

Disclosure(s):

Shrilla Banerjee, MD, FRCP, FESC: General Electric: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, September 10, 2025)

Nathaniel R. Smilowitz, MD: Abbott Vascular,: Consulting Fees (e.g., advisory boards) (Ongoing); AngioInsight: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)

Brian C. Case, MD: Acist Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Zoll Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Jeff W. Chambers, MD, FSCAI, FACC: Zoll/Therox: Consulting Fees (e.g., advisory boards) (Ongoing)

Timothy D. Henry, MD: No financial relationships to disclose

Amir Lerman, MD: Philips: Consulting Fees (e.g., advisory boards) (Ongoing)

Jean-Michel Paradis, MD: No financial relationships to disclose

Robert S. Schwartz, MD, FACC, FSCAI: Autonomix LLC: Employee (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock Options [in privately held companies] (Ongoing), Stock-publicly held company (excluding mutual/index funds) (Ongoing)

Janet Wei, MD: No financial relationships to disclose